Voyager Therapeutics inks deal with AbbVie to develop anti-tau antibodies in neurodegenerative diseases [Seeking Alpha]
Voyager Therapeutics, Inc. (VYGR)
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.voyagertherapeutics.com
Company Research
Source: Seeking Alpha
Voyager Therapeutics inks deal with AbbVie to develop anti-tau antibodies in neurodegenerative diseasesThinly traded small cap Voyager Therapeutics (NASDAQ:VYGR) enters into an exclusiveagreement with AbbVie (NYSE:ABBV) aimed at developing and commercializing vectorized antibodies directed against tau for the treatment neurodegenerative diseases including Alzheimer's.The partnership leverages AbbVie's expertise in monoclonal antibodies and its global development and commercial strengths with Voyager's gene therapy platform and AAV vector know-how.Under the terms of the deal, Voyager will receive $69M upfront, up to $155M in preclinical and Phase 1 option payments, up to $895M in development ;and regulatory milestones for each vectorized tau antibody compound and tiered royalties on net sales.Voyager will be responsible for research and preclinical activities. AbbVie will select one or more vectorized antibodies to advance into IND-enabling studies and clinical development. Voyager wil
Show less
Read more
Impact Snapshot
Event Time:
VYGR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VYGR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VYGR alerts
High impacting Voyager Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VYGR
News
- Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingGlobeNewswire
- Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentGlobeNewswire
- NorthStar Appoints Peter Pfreundschuh to Board of Managers [Yahoo! Finance]Yahoo! Finance
- NorthStar Appoints Peter Pfreundschuh to Board of ManagersBusiness Wire
VYGR
Earnings
- 2/28/24 - Beat
VYGR
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- VYGR's page on the SEC website